McKesson revenue increased from $214.3 billion in 2019 to $231.1 billion in 2020, a 7.8% increase.

Annual Revenue ($)

McKesson revenue was $231.05 b in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$198.53 b$208.36 b$214.32 b$231.05 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$51.05 b$52.06 b$53.62 b$52.61 b$53.08 b$56.21 b$55.73 b$57.62 b$59.17 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

McKesson revenue breakdown by business segment: 39.0% from U.S. Pharmaceutical and Specialty Solutions, 6.6% from European Pharmaceutical Solutions, 49.9% from Distribution Solutions and 4.5% from Other

McKesson revenue breakdown by geographic segment: 81.6% from United States and 18.4% from Foreign

FY, 2019FY, 2017FY, 2018
Other 11.70 b12.21 b11.84 b
Medical-Surgical Solutions7.62 b6.24 b6.61 b
U.S. Pharmaceutical and Specialty Solutions167.76 b155.24 b162.59 b
European Pharmaceutical Solutions27.24 b24.85 b27.32 b
Distribution Solutions208.12 b
Technology Solutions240 m
FY, 2019FY, 2017FY, 2018
United States176.30 b164.43 b169.94 b
Foreign38.02 b34.11 b38.41 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.